National Transmural Agreements on chronic kidney failure;Landelijke Transmurale Afspraak Chronische nierschade

Huisarts en Wetenschap

Volumn 52, Issue 12, 2009, Pages 586-597

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CALCIUM PHOSPHATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

CARDIOVASCULAR RISK; CHRONIC DISEASE; HUMAN; KIDNEY FUNCTION; KIDNEY INJURY; MICROALBUMINURIA; PATHOPHYSIOLOGY; PROTEINURIA; REVIEW; RISK FACTOR;

EID: 72449169446     PISSN: 00187070     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03085802     Document Type: Review

References (68)

1. Ahmad J, Siddiqui MA, Ahmad H. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria. Diabetes Care 1997;20:1576-1581 (Pubitemid 27415037)
2. Anonymus. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet 2000;355:253-259
3. Asselbergs FW, Diercks GF, Hillege HL, Van Boven AJ, Janssen WM, Voors AA, et al. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation 2004;110:2809-2816
4. Avorn J, Bohn RL, Levy E, Levin R, Owen WF, Jr., Winkelmayer WC, et al. Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med 2002;162:2002-6.
5. Bakker AJ, De Grauw WJ. Methoden van urineverzameling voor het bepalen van microalbuminurie: tijd voor consensus. Ned Tijdschr Geneeskd 2004;148:2012-2015 (Pubitemid 39362026)
6. Bergstrom J, Alvestrand A, Bucht H, Gutierrez A. Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. Clin Nephrol 1986;25:1-6. (Pubitemid 16187263)
7. Berl T, Henrich W. Kidney-heart interactions: epidemiology, pathogenesis, and treatment. Clin J Am Soc Nephrol 2006;1:8-18.
8. Bilous R. Blood pressure control in type 2 diabetes - what does the United KingdomProspective Diabetes Study (UKPDS) tell us? Nephrol Dial Transplant 1999;14:2562-2564 (Pubitemid 32208359)
9. Bo S, Ciccone G, Rosato R, Gancia R, Grassi G, Merletti F, et al. Renal damage in patients with Type 2 diabetes: a strong predictor of mortality. Diabet Med 2005;22:258-265 (Pubitemid 40313851)
10. Brenner BM, Cooper ME, De Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-869 (Pubitemid 34940825)
11. Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003;14:1480-1486 (Pubitemid 36687049)
12. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572 (Pubitemid 37430158)
13. Chuahirun T, Simoni J, Hudson C, Seipel T, Khanna A, Harrist RB, et al. Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes. Am J Med Sci 2004;327:57-67.
14. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
15. Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007;334:885-888 (Pubitemid 46724330)
16. De Grauw WJ, Van de Lisdonk EH, Van de Hoogen HJ, Van Gerwen WH, Van den Bosch WJ, Willems JL, et al. Screening for microalbuminuria in type 2 diabetic patients: the evaluation of a dipstick test in general practice. Diabet Med 1995;12:657-663
17. Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997;157:1413-1418
18. Eadington DW. Delayed referral for dialysis. Nephrol Dial Transplant 1996;11:2124-2126
19. Ejerblad E, Fored CM, Lindblad P, Fryzek J, Dickman PW, Elinder CG, et al. Association between smoking and chronic renal failure in a nationwide population-based case-control study. J Am Soc Nephrol 2004;15:2178-2185 (Pubitemid 39031356)
20. European Society of Hypertension (ESH) and European Society of Cardiology (ESC) Task Force. Summary of the 2007 European Society of Hypertension (ESH) and European Society of Cardiology (ESC) guidelines for the management of arterial hypertension. Vasc Health Risk Manag 2007;3:783-795
21. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-1305
22. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK. Dietary sodium intake and incidence of congestive heart failure in overweight US men and women: first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Arch Intern Med 2002;162:1619-1624 (Pubitemid 34765011)
23. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006;144:21-28 (Pubitemid 46780716)
24. Iseki K. Body mass index and the risk of chronic renal failure: the Asian experience. Contrib Nephrol 2006;151:42-56. (Pubitemid 44298223)
25. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004;65:1870-1876 (Pubitemid 38591038)
26. Kemperman FA, Krediet RT, Arisz L. Formula-derived prediction of the glomerular filtration rate from plasma creatinine concentration. Nephron 2002;91:547-558 (Pubitemid 34914052)
27. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 1994;330:877-884
28. KNMP-WINAp. Verminderde nierfunctie. Doseringsadviezen voor geneesmiddelen. Den Haag: KNMP, 2009.
29. Krikken JA, Lely AT, Bakker SJL, Navis G. The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int 2007;71:260-265 (Pubitemid 46160927)
30. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470 (Pubitemid 29135798)
31. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003;139:137-147 (Pubitemid 38129105)
32. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-254 (Pubitemid 46768608)
33. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007;53:766-772 (Pubitemid 46580250)
34. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-860 (Pubitemid 34940824)
35. Melander O, Von Wowern F, Frandsen E, Burri P, Willsteen G, Aurell M, et al. Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma. J Hypertens 2007;25:619-627 (Pubitemid 46213801)
36. Mogensen CE. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. J Intern Med 2003;254:45-66. (Pubitemid 36819130)
37. Morales E, Valero MA, Leon M, Hernandez E, Praga M. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 2003;41:319-27.
38. NHG. NHG-Standaard Diabetes mellitus type 2. Tweede herziening (2006). http://nhg.artsen-net.nl/kenniscentrum/k-richtlijnen/k-NHG-standaarden.
39. NHG. NHG-Standaard Cardiovasculair risicomanagement. In: Wiersma Tj, Boukes FS, Geijer RMM, Goudswaard AN, redactie. NHG-Standaarden voor de huisarts 2009. Houten; Bonn Stafleu van Loghum, 2009.
40. NICE. Chronic Kidney Disease (2008). http://www.nice.org.uk/nicemedia/ pdf/CG073Full-Guideline.pdf.
41. Nierstichting. Feiten en cijfers 2008). http://www.nierstichting.nl/ ziekte/feiten-en-cijfers.Geraadpleegd op 14 juli 2008.
42. NIV/CBO. Richtlijn diabetische nefropathie (2006). http://www. internisten.nl〉richtlijnen.
43. NIV/nfN. Richtlijn voor de behandeling van patiënten met chronische nierschade (2009). http://www.nefro.nl〉richtlijnen.
44. Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001;345:870-878 (Pubitemid 34940826)
45. Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E. et al. Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol 2009;20:205-212
46. Perneger TV, Nieto FJ, Whelton PK, Klag MJ, Comstock GW, Szklo M. A prospective study of blood pressure and serum creatinine. Results from the 'Clue' Study and the ARIC Study. JAMA 1993;269:488-493
47. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med 1995;123:754-762
48. Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JTJ, Whelton PK et al. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med 2006;144:172-180
49. Ravid M, Lang R, Rachmani R, Lishner M. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. Arch Intern Med 1996;156:286-289
50. Romero R, Salinas I, Lucas A, Abad E, Reverter JL, Johnston S, et al. Renal function changes in microalbuminuric normotensive type II diabetic patients treated with angiotensin-converting enzyme inhibitors. Diabetes Care 1993;16:597-600. (Pubitemid 23097208)
51. Rosansky SJ, Hoover DR, King L, Gibson J. The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects. Arch Intern Med 1990;150:2073-2076 (Pubitemid 20348357)
52. Rostand SG, Drueke TB. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 1999;56:383-92.
53. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001;344:3-10.
54. Sano T, Hotta N, Kawamura T, Matsumae H, Chaya S, Sasaki H, et al. Effects of long-term enalapril treatment on persistent microalbuminuria in normotensive type 2 diabetic patients: results of a 4-year, prospective, randomized study. Diabet Med 1996;13:120-124 (Pubitemid 26074289)
55. Schiffl H, Lang SM, Fischer R, Stopping smoking slows accelerated progression of renal failure in primary renal disease. J Nephrol 2002;15:270-274 (Pubitemid 34830534)
56. Segura J, Ruilope LM, Zanchetti A. On the importance of estimating renal function for cardiovascular risk assessment. J Hypertens 2004;22:1635-1639 (Pubitemid 39141949)
57. Shankar A, Klein R, Klein BE. The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol 2006;164:263-71.
58. Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathy patients. Kidney Int 1985;28:830-838 (Pubitemid 16156326)
59. Shulman NB, Ford CE, Hall WD, Blaufox MD, Simon D, Langford HG, et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1989;13:180-193.
60. Speckman RA, McClellan WM, Volkova NV, Jurkovitz CT, Satko SG, Schoolwerth AC, et al. Obesity is associated with family history of ESRD in incident dialysis patients. Am J Kidney Dis 2006;48:50-58
61. Stichting Renine. Registratie Nierfunktievervanging (2007). http://www.renine.nl. Geraadpleegd 11 juni 2007.
62. Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S. Influence of smoking and obesity on the development of proteinuria. Kidney Int 2002;62:956-962 (Pubitemid 35316725)
63. Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, Pietinen P, et al. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 2001;357:848-851
64. Van der Snoek BE, Hoitsma AJ, Van Weel C, Koene RA. Dysmorfe erytrocyten in het urine-sediment bij het onderscheiden van urologische en nefrologische oorzaken van hematurie. Ned Tijdschr Geneeskd 1994;138:721-726 (Pubitemid 24110188)
65. Verhave JC, Hillege HL, Burgerhof JGM, Janssen WMT, Gansevoort RT, Navis GJ, et al. Sodium intake affects urinary albumin excretion especially in overweight subjects. J Intern Med 2004;256:324-330
66. Walker WG. Neaton JD, Cutler JA, Neuwirth R, Cohen JD. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. JAMA 1992;268:3085-3091
67. Wetzels JF, Kiemeney LA, Swinkels DW, Willems HL, Den Heijer M. Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int 2007;72:632-637
68. Whelton PK, He J, Perneger TV, Klag MJ. Kidney damage in 'benign' essential hypertension. Curr Opin Nephrol Hypertens 1997;6:177-183